M31 Technology Corporation (TPEX:6643)

CTI BioPharma Statistics

Total Valuation

M31 Technology has a market cap or net worth of TWD 20.59 billion. The enterprise value is 20.11 billion.

Market Cap	20.59B
Enterprise Value	20.11B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	Jul 1, 2025

Share Statistics

M31 Technology has 41.80 million shares outstanding. The number of shares has decreased by -0.41% in one year.

Current Share Class	41.80M
Shares Outstanding	41.80M
Shares Change (YoY)	-0.41%
Shares Change (QoQ)	-0.46%
Owned by Insiders (%)	30.78%
Owned by Institutions (%)	19.08%
Float	26.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	66.92
PS Ratio	12.92
PB Ratio	11.41
P/TBV Ratio	11.51
P/FCF Ratio	n/a
P/OCF Ratio	800.65
PEG Ratio	0.96

Enterprise Valuation

EV / Earnings	-432.79
EV / Sales	12.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-480.95

Financial Position

The company has a current ratio of 4.87, with a Debt / Equity ratio of 0.01.

Current Ratio	4.87
Quick Ratio	3.65
Debt / Equity	0.01
Debt / EBITDA	0.32
Debt / FCF	-0.42
Interest Coverage	-6.47

Financial Efficiency

Return on equity (ROE) is -2.48% and return on invested capital (ROIC) is -0.31%.

Return on Equity (ROE)	-2.48%
Return on Assets (ROA)	-0.26%
Return on Invested Capital (ROIC)	-0.31%
Return on Capital Employed (ROCE)	-0.51%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.71
Inventory Turnover	n/a

Taxes

Income Tax	-7.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.21% in the last 52 weeks. The beta is 0.78, so M31 Technology's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-40.21%
50-Day Moving Average	514.97
200-Day Moving Average	632.02
Relative Strength Index (RSI)	51.62
Average Volume (20 Days)	794,735

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, M31 Technology had revenue of TWD 1.59 billion and -46.46 million in losses. Loss per share was -1.12.

Revenue	1.59B
Gross Profit	1.59B
Operating Income	-9.34M
Pretax Income	-54.21M
Net Income	-46.46M
EBITDA	45.19M
EBIT	-9.34M
Loss Per Share	-1.12

Balance Sheet

The company has 497.06 million in cash and 17.72 million in debt, giving a net cash position of 479.34 million or 11.47 per share.

Cash & Cash Equivalents	497.06M
Total Debt	17.72M
Net Cash	479.34M
Net Cash Per Share	11.47
Equity (Book Value)	1.80B
Book Value Per Share	43.37
Working Capital	920.10M

Cash Flow

In the last 12 months, operating cash flow was 25.71 million and capital expenditures -67.52 million, giving a free cash flow of -41.81 million.

Operating Cash Flow	25.71M
Capital Expenditures	-67.52M
Free Cash Flow	-41.81M
FCF Per Share	-1.00

Margins

Gross margin is 100.00%, with operating and profit margins of -0.59% and -2.92%.

Gross Margin	100.00%
Operating Margin	-0.59%
Pretax Margin	-3.40%
Profit Margin	-2.92%
EBITDA Margin	2.84%
EBIT Margin	-0.59%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.39%.

Dividend Per Share	2.00
Dividend Yield	0.39%
Dividend Growth (YoY)	-75.00%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	0.41%
Shareholder Yield	0.80%
Earnings Yield	-0.23%
FCF Yield	-0.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 25, 2024. It was a forward split with a ratio of 1.2.

Last Split Date	Jun 25, 2024
Split Type	Forward
Split Ratio	1.2

Scores

M31 Technology has an Altman Z-Score of 78.53 and a Piotroski F-Score of 3.

Altman Z-Score	78.53
Piotroski F-Score	3